Byeong-Bae Park
Overview
Explore the profile of Byeong-Bae Park including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
496
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Song M, Park B, Uhm J
Int J Mol Sci
. 2022 Oct;
23(20).
PMID: 36293564
FLT3 mutations are the most common genomic alteration detected in acute myeloid leukemia (AML) with a worse clinical prognosis. The highly frequent FLT3 mutations, together with the side effects associated...
2.
Song M, Park B, Uhm J
Int J Mol Sci
. 2021 Jun;
22(11).
PMID: 34071627
Acute myeloid leukemia (AML) is a heterogenous hematopoietic neoplasm with various genetic abnormalities in myeloid stem cells leading to differentiation arrest and accumulation of leukemic cells in bone marrow (BM)....
3.
Song M, Park B, Uhm J
Int J Mol Sci
. 2019 Oct;
20(20).
PMID: 31658644
Chimeric antigen receptor (CAR) T-cell therapy has shown promising clinical impact against hematologic malignancies. CD19 is a marker on the surface of normal B cells as well as most B-cell...
4.
Park B, Kim W, Suh C, Hong J, Yang D, Lee W, et al.
Leuk Lymphoma
. 2019 Jun;
60(13):3251-3257.
PMID: 31170847
This trial was designed to investigate the efficacy and toxicity of bendamustine, carboplatin, and dexamethasone (BCD) for relapsed or refractory peripheral T-cell lymphomas (PTCLs), which would be expected to exhibit...
5.
Song M, Park B, Uhm J
Int J Mol Sci
. 2019 Mar;
20(6).
PMID: 30884772
In tumor microenvironment, the programmed death 1 (PD-1) immune checkpoint has a crucial role of mechanism of T cell exhaustion leading to tumor evasion. Ligands of PD-1, programmed death ligand...
6.
Oh S, Kim W, Kang H, Lee J, Huh S, Kim S, et al.
Ann Hematol
. 2018 Jun;
97(10):1851-1857.
PMID: 29947974
Both-side synchronous involvement has been reported to account for 7-24% of ocular adnexal marginal zone lymphoma (OAML). We conducted a retrospective analysis to identify the clinical features and treatment outcomes...
7.
Song M, Park B, Uhm J
Int J Mol Sci
. 2018 Mar;
19(3).
PMID: 29562644
Myelofibrosis (MF) is a clinical manifestation of chronic BCR-ABL1-negative chronic myeloproliferative neoplasms. Splenomegaly is one of the major clinical manifestations of MF and is directly linked to splenic extramedullary hematopoiesis...
8.
Go S, Koo D, Kim S, Song H, Kim R, Jang J, et al.
Oncologist
. 2017 Jul;
22(11):1354-1361.
PMID: 28687626
Background: To assess whether the rotation of dexamethasone to methylprednisolone decreases the intensity of dexamethasone-induced hiccup (DIH) in cancer patients treated with chemotherapy. Materials And Methods: Adult patients who experienced...
9.
The Consortium for Improving Survival of Lymphoma (CISL): recent achievements and future perspective
Suh C, Park B, Kim W
Blood Res
. 2017 Apr;
52(1):3-6.
PMID: 28401092
No abstract available.
10.
Lee H, Kim S, Kim I, Kim Y, Kim J, Kim Y, et al.
Blood Res
. 2015 Oct;
50(3):160-6.
PMID: 26457283
Background: Among the currently available prognostic models for diffuse large B-cell lymphoma (DLBCL), we investigated to determine which is most adoptable for DLBCL patients treated with rituximab, cyclophosphamide, doxorubicin, vincristine,...